Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

Purpose Lenalidomide maintenance therapy after autologous stem-cell transplantation (ASCT) demonstrated prolonged progression-free survival (PFS) versus placebo or observation in several randomized controlled trials (RCTs) of patients with newly diagnosed multiple myeloma (NDMM). All studies had PFS...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical oncology Ročník 35; číslo 29; s. 3279
Hlavní autori:	McCarthy, Philip L, Holstein, Sarah A, Petrucci, Maria Teresa, Richardson, Paul G, Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C, Caillot, Denis, Gay, Francesca, Moreau, Philippe, Marit, Gerald, Jung, Sin-Ho, Yu, Zhinuan, Winograd, Benjamin, Knight, Robert D, Palumbo, Antonio, Attal, Michel
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 10.10.2017
Predmet:	Adult Aged Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - adverse effects Chemotherapy, Adjuvant Disease Progression Disease-Free Survival Drug Administration Schedule Female Humans Kaplan-Meier Estimate Lenalidomide Maintenance Chemotherapy Male Middle Aged Multiple Myeloma - diagnosis Multiple Myeloma - mortality Multiple Myeloma - therapy Randomized Controlled Trials as Topic Risk Factors Stem Cell Transplantation - adverse effects Stem Cell Transplantation - mortality Thalidomide - administration & dosage Thalidomide - adverse effects Thalidomide - analogs & derivatives Time Factors Transplantation, Autologous Treatment Outcome Young Adult
ISSN:	1527-7755, 1527-7755
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!